[1]
Hirata A, Murakami KS. Archaeal RNA polymerase. Current opinion in structural biology. 2009 Dec:19(6):724-31. doi: 10.1016/j.sbi.2009.10.006. Epub 2009 Oct 31
[PubMed PMID: 19880312]
Level 3 (low-level) evidence
[2]
Decker KB, Hinton DM. Transcription regulation at the core: similarities among bacterial, archaeal, and eukaryotic RNA polymerases. Annual review of microbiology. 2013:67():113-39. doi: 10.1146/annurev-micro-092412-155756. Epub 2013 Jun 13
[PubMed PMID: 23768203]
[3]
Jun SH, Reichlen MJ, Tajiri M, Murakami KS. Archaeal RNA polymerase and transcription regulation. Critical reviews in biochemistry and molecular biology. 2011 Feb:46(1):27-40. doi: 10.3109/10409238.2010.538662. Epub
[PubMed PMID: 21250781]
[4]
Ebright RH. RNA polymerase: structural similarities between bacterial RNA polymerase and eukaryotic RNA polymerase II. Journal of molecular biology. 2000 Dec 15:304(5):687-98
[PubMed PMID: 11124018]
[5]
Strathern JN, Jin DJ, Court DL, Kashlev M. Isolation and characterization of transcription fidelity mutants. Biochimica et biophysica acta. 2012 Jul:1819(7):694-9. doi: 10.1016/j.bbagrm.2012.02.005. Epub 2012 Feb 16
[PubMed PMID: 22366339]
[6]
Reynolds NM, Lazazzera BA, Ibba M. Cellular mechanisms that control mistranslation. Nature reviews. Microbiology. 2010 Dec:8(12):849-56. doi: 10.1038/nrmicro2472. Epub
[PubMed PMID: 21079633]
[7]
Zhou YN, Lubkowska L, Hui M, Court C, Chen S, Court DL, Strathern J, Jin DJ, Kashlev M. Isolation and characterization of RNA polymerase rpoB mutations that alter transcription slippage during elongation in Escherichia coli. The Journal of biological chemistry. 2013 Jan 25:288(4):2700-10. doi: 10.1074/jbc.M112.429464. Epub 2012 Dec 5
[PubMed PMID: 23223236]
[8]
Naryshkin N, Revyakin A, Kim Y, Mekler V, Ebright RH. Structural organization of the RNA polymerase-promoter open complex. Cell. 2000 Jun 9:101(6):601-11
[PubMed PMID: 10892647]
[9]
Ross W, Gosink KK, Salomon J, Igarashi K, Zou C, Ishihama A, Severinov K, Gourse RL. A third recognition element in bacterial promoters: DNA binding by the alpha subunit of RNA polymerase. Science (New York, N.Y.). 1993 Nov 26:262(5138):1407-13
[PubMed PMID: 8248780]
[10]
Campbell EA, Muzzin O, Chlenov M, Sun JL, Olson CA, Weinman O, Trester-Zedlitz ML, Darst SA. Structure of the bacterial RNA polymerase promoter specificity sigma subunit. Molecular cell. 2002 Mar:9(3):527-39
[PubMed PMID: 11931761]
[11]
Murakami KS, Masuda S, Campbell EA, Muzzin O, Darst SA. Structural basis of transcription initiation: an RNA polymerase holoenzyme-DNA complex. Science (New York, N.Y.). 2002 May 17:296(5571):1285-90
[PubMed PMID: 12016307]
[12]
Murakami KS, Darst SA. Bacterial RNA polymerases: the wholo story. Current opinion in structural biology. 2003 Feb:13(1):31-9
[PubMed PMID: 12581657]
Level 3 (low-level) evidence
[13]
Kuznedelov K, Minakhin L, Niedziela-Majka A, Dove SL, Rogulja D, Nickels BE, Hochschild A, Heyduk T, Severinov K. A role for interaction of the RNA polymerase flap domain with the sigma subunit in promoter recognition. Science (New York, N.Y.). 2002 Feb 1:295(5556):855-7
[PubMed PMID: 11823642]
[14]
Mekler V, Kortkhonjia E, Mukhopadhyay J, Knight J, Revyakin A, Kapanidis AN, Niu W, Ebright YW, Levy R, Ebright RH. Structural organization of bacterial RNA polymerase holoenzyme and the RNA polymerase-promoter open complex. Cell. 2002 Mar 8:108(5):599-614
[PubMed PMID: 11893332]
[15]
Vassylyev DG, Sekine S, Laptenko O, Lee J, Vassylyeva MN, Borukhov S, Yokoyama S. Crystal structure of a bacterial RNA polymerase holoenzyme at 2.6 A resolution. Nature. 2002 Jun 13:417(6890):712-9
[PubMed PMID: 12000971]
[16]
Bae B, Feklistov A, Lass-Napiorkowska A, Landick R, Darst SA. Structure of a bacterial RNA polymerase holoenzyme open promoter complex. eLife. 2015 Sep 8:4():. doi: 10.7554/eLife.08504. Epub 2015 Sep 8
[PubMed PMID: 26349032]
[17]
Mukhopadhyay J, Das K, Ismail S, Koppstein D, Jang M, Hudson B, Sarafianos S, Tuske S, Patel J, Jansen R, Irschik H, Arnold E, Ebright RH. The RNA polymerase "switch region" is a target for inhibitors. Cell. 2008 Oct 17:135(2):295-307. doi: 10.1016/j.cell.2008.09.033. Epub
[PubMed PMID: 18957204]
[18]
Steitz TA, Steitz JA. A general two-metal-ion mechanism for catalytic RNA. Proceedings of the National Academy of Sciences of the United States of America. 1993 Jul 15:90(14):6498-502
[PubMed PMID: 8341661]
[19]
Nudler E. RNA polymerase backtracking in gene regulation and genome instability. Cell. 2012 Jun 22:149(7):1438-45. doi: 10.1016/j.cell.2012.06.003. Epub
[PubMed PMID: 22726433]
[20]
Gruber TM, Gross CA. Multiple sigma subunits and the partitioning of bacterial transcription space. Annual review of microbiology. 2003:57():441-66
[PubMed PMID: 14527287]
[21]
Hook-Barnard IG, Hinton DM. Transcription initiation by mix and match elements: flexibility for polymerase binding to bacterial promoters. Gene regulation and systems biology. 2007:1():275-93
[PubMed PMID: 19119427]
[22]
Saecker RM, Record MT Jr, Dehaseth PL. Mechanism of bacterial transcription initiation: RNA polymerase - promoter binding, isomerization to initiation-competent open complexes, and initiation of RNA synthesis. Journal of molecular biology. 2011 Oct 7:412(5):754-71. doi: 10.1016/j.jmb.2011.01.018. Epub 2011 Mar 1
[PubMed PMID: 21371479]
[23]
Hsu LM. Promoter clearance and escape in prokaryotes. Biochimica et biophysica acta. 2002 Sep 13:1577(2):191-207
[PubMed PMID: 12213652]
[24]
Platt T. Transcription termination and the regulation of gene expression. Annual review of biochemistry. 1986:55():339-72
[PubMed PMID: 3527045]
[25]
Kuwana M, Kaburaki J, Mimori T, Tojo T, Homma M. Autoantibody reactive with three classes of RNA polymerases in sera from patients with systemic sclerosis. The Journal of clinical investigation. 1993 Apr:91(4):1399-404
[PubMed PMID: 8473491]
[26]
Wirz EG, Jaeger VK, Allanore Y, Riemekasten G, Hachulla E, Distler O, Airò P, Carreira PE, Tikly M, Vettori S, Balbir Gurman A, Damjanov N, Müller-Ladner U, Distler J, Li M, Häusermann P, Walker UA, EUSTAR coauthors. Incidence and predictors of cutaneous manifestations during the early course of systemic sclerosis: a 10-year longitudinal study from the EUSTAR database. Annals of the rheumatic diseases. 2016 Jul:75(7):1285-92. doi: 10.1136/annrheumdis-2015-207271. Epub 2015 Jul 31
[PubMed PMID: 26232495]
[27]
Kuwana M. A To-Do List at Diagnosis of Systemic Sclerosis with Positive Anti-RNA Polymerase III Antibodies. The Journal of rheumatology. 2017 May:44(5):550-552. doi: 10.3899/jrheum.170037. Epub
[PubMed PMID: 28461517]
[28]
Hannan KM, Sanij E, Rothblum LI, Hannan RD, Pearson RB. Dysregulation of RNA polymerase I transcription during disease. Biochimica et biophysica acta. 2013 Mar-Apr:1829(3-4):342-60. doi: 10.1016/j.bbagrm.2012.10.014. Epub 2012 Nov 12
[PubMed PMID: 23153826]
[29]
Severinov K, Mustaev A, Severinova E, Kozlov M, Darst SA, Goldfarb A. The beta subunit Rif-cluster I is only angstroms away from the active center of Escherichia coli RNA polymerase. The Journal of biological chemistry. 1995 Dec 8:270(49):29428-32
[PubMed PMID: 7493980]
[30]
Campbell EA, Korzheva N, Mustaev A, Murakami K, Nair S, Goldfarb A, Darst SA. Structural mechanism for rifampicin inhibition of bacterial rna polymerase. Cell. 2001 Mar 23:104(6):901-12
[PubMed PMID: 11290327]
[31]
McClure WR, Cech CL. On the mechanism of rifampicin inhibition of RNA synthesis. The Journal of biological chemistry. 1978 Dec 25:253(24):8949-56
[PubMed PMID: 363713]
[32]
Mosaei H, Harbottle J. Mechanisms of antibiotics inhibiting bacterial RNA polymerase. Biochemical Society transactions. 2019 Feb 28:47(1):339-350. doi: 10.1042/BST20180499. Epub 2019 Jan 15
[PubMed PMID: 30647141]
[33]
Lin W, Das K, Degen D, Mazumder A, Duchi D, Wang D, Ebright YW, Ebright RY, Sineva E, Gigliotti M, Srivastava A, Mandal S, Jiang Y, Liu Y, Yin R, Zhang Z, Eng ET, Thomas D, Donadio S, Zhang H, Zhang C, Kapanidis AN, Ebright RH. Structural Basis of Transcription Inhibition by Fidaxomicin (Lipiarmycin A3). Molecular cell. 2018 Apr 5:70(1):60-71.e15. doi: 10.1016/j.molcel.2018.02.026. Epub 2018 Mar 29
[PubMed PMID: 29606590]
[34]
Boyaci H, Chen J, Lilic M, Palka M, Mooney RA, Landick R, Darst SA, Campbell EA. Fidaxomicin jams Mycobacterium tuberculosis RNA polymerase motions needed for initiation via RbpA contacts. eLife. 2018 Feb 26:7():. doi: 10.7554/eLife.34823. Epub 2018 Feb 26
[PubMed PMID: 29480804]
[35]
Perry RP, Kelley DE. Inhibition of RNA synthesis by actinomycin D: characteristic dose-response of different RNA species. Journal of cellular physiology. 1970 Oct:76(2):127-39
[PubMed PMID: 5500970]
[36]
Sobell HM. Actinomycin and DNA transcription. Proceedings of the National Academy of Sciences of the United States of America. 1985 Aug:82(16):5328-31
[PubMed PMID: 2410919]
[37]
Rudd MD, Luse DS. Amanitin greatly reduces the rate of transcription by RNA polymerase II ternary complexes but fails to inhibit some transcript cleavage modes. The Journal of biological chemistry. 1996 Aug 30:271(35):21549-58
[PubMed PMID: 8702941]
[38]
Brueckner F, Cramer P. Structural basis of transcription inhibition by alpha-amanitin and implications for RNA polymerase II translocation. Nature structural & molecular biology. 2008 Aug:15(8):811-8. doi: 10.1038/nsmb.1458. Epub 2008 Jun 13
[PubMed PMID: 18552824]
[39]
Fraser RS, Creanor J. The mechanism of inhibition of ribonucleic acid synthesis by 8-hydroxyquinoline and the antibiotic lomofungin. The Biochemical journal. 1975 Jun:147(3):401-10
[PubMed PMID: 810137]